Quantcast
Brazil company requests emergency authorization to use India’s Covaxin – Metro US

Brazil company requests emergency authorization to use India’s Covaxin

FILE PHOTO: COVID-19 vaccination in New Delhi
FILE PHOTO: COVID-19 vaccination in New Delhi

SAO PAULO (Reuters) – Brazilian company Precisa Medicamentos, representing India’s Bharat Biotech, on Monday said it requested that the country’s health regulator, Anvisa, grant emergency authorization to use the Covaxin COVID-19 vaccine.

In addition, it said Covaxin would be trialed in a Phase Three study in Brazil carried out in partnership with Sao Paulo’s Albert Einstein hospital.

(Reporting by Marcelo Rochabrun; Editing by Leslie Adler)

More from our Sister Sites